Kees Nooter

10.9k total citations · 2 hit papers
149 papers, 9.1k citations indexed

About

Kees Nooter is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Kees Nooter has authored 149 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 67 papers in Molecular Biology and 21 papers in Hematology. Recurrent topics in Kees Nooter's work include Drug Transport and Resistance Mechanisms (47 papers), Cancer therapeutics and mechanisms (37 papers) and Cancer Treatment and Pharmacology (19 papers). Kees Nooter is often cited by papers focused on Drug Transport and Resistance Mechanisms (47 papers), Cancer therapeutics and mechanisms (37 papers) and Cancer Treatment and Pharmacology (19 papers). Kees Nooter collaborates with scholars based in Netherlands, United States and North Macedonia. Kees Nooter's co-authors include Alex Sparreboom, Jaap Verweij, G. Stoter, Hans Gelderblom, Pieter Sonneveld, Hans Herweijer, Walter J. Loos, Herman Burger, Antonius W.M. Boersma and Peter de Bruijn and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Kees Nooter

148 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cremophor EL

2001 1.4k citations Hans Gelderblom, Jaap Verweij et al. European Journal of Cancer profile →
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

2001 626 citations Ron H.J. Mathijssen, Jaco J. Verweij et al. PubMed profile →

Peers

Countries citing papers authored by Kees Nooter

Since Specialization

Citations

This map shows the geographic impact of Kees Nooter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees Nooter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees Nooter more than expected).

Fields of papers citing papers by Kees Nooter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kees Nooter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees Nooter. The network helps show where Kees Nooter may publish in the future.

Co-authorship network of co-authors of Kees Nooter

This figure shows the co-authorship network connecting the top 25 collaborators of Kees Nooter. A scholar is included among the top collaborators of Kees Nooter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kees Nooter. Kees Nooter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors 2006 ·Cancer Chemotherapy and Pharmacology ·Alessandra Felici, Walter J. Loos, Jaap Verweij, (unknown), Peter de Bruijn, Kees Nooter, Ron H.J. Mathijssen, Maja J.A. de Jonge	13
2	Cytotoxicity of oleandrin isolated from the leaves of Nerium indicum Mill. on several human cancer cell lines 2005 ·INDONESIAN JOURNAL OF PHARMACY ·(unknown), (unknown), (unknown), Kees Nooter, Ibnu Gholib Gandjar, Subagus Wahyuono	2
3	Pharmacokinetic Resistance to Imatinib Mesylate: Role of the ABC Drug Pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the Oral Bioavailability of Imatinib 2004 ·Cell Cycle ·(unknown), Kees Nooter	84
4	Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis 2003 ·Anti-Cancer Drugs ·Walter J. Loos, Hans Gelderblom, Jaap Verweij, (unknown), Kees Nooter, G. Stoter, Alex Sparreboom	12
5	Anticancer Drug Resistance Induced by Disruption of the Saccharomyces cerevisiae NPR2 Gene: a Novel Component Involved in Cisplatin- and Doxorubicin-Provoked Cell Kill 2003 ·Molecular Pharmacology ·Paul W. Schenk, Mariël Brok, Antonius W.M. Boersma, Jourica A. Brandsma, Hans den Dulk, Herman Burger, G. Stoter, Jaap Brouwer, Kees Nooter	42
6	Functional cloning of drug resistance genes from retroviral cDNA libraries 2003 ·Biochemical and Biophysical Research Communications ·Peter T. Bosma, (unknown), Nicolaas G.J. Jaspers, G. Stoter, Kees Nooter	2
7	Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens 2003 ·European Journal of Cancer ·Henry Burger, Michael A. den Bakker, G. Stoter, Jaap Verweij, Kees Nooter	54
8	Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel. 2002 ·PubMed ·Hans Gelderblom, Jaap Verweij, (unknown), (unknown), (unknown), Kees Nooter, G. Stoter, Alex Sparreboom	83
9	Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933 2002 ·European Journal of Cancer ·Lia van Zuylen, Alex Sparreboom, Ate van der Gaast, Kees Nooter, Ferry A.L.M. Eskens, E. Brouwer, C.J. Bol, Ronald P. de Vries, Peter Palmer, Jaap Verweij	55
10	Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatography 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Walter J. Loos, Peter de Bruijn, Lia van Zuylen, Jaap Verweij, Kees Nooter, G. Stoter, Alex Sparreboom	28
11	Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and feces 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·Alex Sparreboom, Peter de Bruijn, Maja J.A. de Jonge, Walter J. Loos, Gerrit Stoter, Jaap Verweij, Kees Nooter	72
12	蛍光検出逆相高速液体クロマトグラフィーによるヒト血しょう中イリノテカン(CPT‐11)とその活性代謝産物SN‐38の定量 1997 ·Journal of Chromatography B ·(unknown), Jaco J. Verweij, Walter J. Loos, Kees Nooter, G. Stoter, Alex Sparreboom	20
13	DI-n-BUTYL-, TRI-n-BUTYL- AND TRIPHENYLTIN STEROIDCARBOXYLATES: SYNTHESIS, NMR CHARACTERIZATION AND IN VITRO ANTITUMOUR ACTIVITY 1997 ·Main Group Metal Chemistry ·Rudolph Willem, Hassan Dalil, P. Broekaert, Monique Biesemans, (unknown), Kees Nooter, Dick de Vos, François Ribot, Marcel Gielen	27
14	The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer 1997 ·British Journal of Cancer ·Kees Nooter, Guy Brutel de la Rivière, Maxime P. Look, Kyra E. van Wingerden, S.C. Henzen‐Logmans, Rik J. Scheper, M J Flens, J.G.M. Klijn, G. Stoter, John A. Foekens	116
15	Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometry 1997 ·Cytometry ·Antonius W.M. Boersma, Kees Nooter, Herman Burger, (unknown), G. Stoter	44
16	Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin 1996 ·Cytometry ·Antonius W.M. Boersma, Kees Nooter, Robert Oostrum, Gerrit Stoter	142
17	A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance 1991 ·British Journal of Cancer ·Jaap Verweij, Hans Herweijer, R. Oosterom, (unknown), A.S.T. Planting, Caroline Seynaeve, G. Stoter, Kees Nooter	59
18	Overexpression of the MDRL gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin‐A 1990 ·International Journal of Cancer ·Kees Nooter, Pieter Sonneveld, Robert Oostrum, Hans Herweijer, (unknown), Dinko Valerio	113
19	Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by Cyclosporine 1990 ·JNCI Journal of the National Cancer Institute ·Hans Herweijer, Pieter Sonneveld, Frank Baas, Kees Nooter	187
20	Cytopathogenic XC assay for bone marrow from mice infected with murine leukemia viruses. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Kees Nooter, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact